Consistently, we found that gastric cancer samples with highly expressed TGF-β1 had an immuno-excluded phenotype, both in TGF-β1 + MFC cell-engrafted mice (Figure 5A) or clinical gastric cancer specimens (Figure 6). This evidence concerns the gene TGFB1 and gastric cancer.